全国87家医院2012-2014年肿瘤患者止吐药使用情况分析
x

请在关注微信后,向客服人员索取文件

篇名: 全国87家医院2012-2014年肿瘤患者止吐药使用情况分析
TITLE:
摘要: 目的:为肿瘤患者止吐药的合理使用提供参考。方法:分别按年度、医院类型对2012-2014年“医院处方分析”项目87家参与单位的门诊、住院肿瘤患者止吐药使用相关数据进行统计分析。结果:2012-2014年87家医院共使用止吐药14种,在门诊肿瘤患者中的销售金额、使用人次分别为576.3万元、3.4万人次[平均2.2万元/(年·家)、133.1人次/(年·家)],住院肿瘤患者为6 171.1万元、51.5万人次[平均25.6万元/(年·家)、2 137.9人次/(年·家)],门诊数据小于住院数据。各年度止吐药在门诊、住院肿瘤患者所用药物中的销售金额占比为5.2‰~34.0‰,使用人次占比为2.9%~10.9%,整体使用住院患者大于门诊患者、专科医院大于综合医院;使用较多的药物为昂丹司琼、托烷司琼、甲氧氯普胺和帕洛诺司琼。结论:止吐药在肿瘤患者中应用较多,尤以5-羟色胺(5-HT3)受体拮抗药、甲氧氯普胺多用。
ABSTRACT: OBJECTIVE: To provide reference for rational use of antiemetics in cancer patients. METHODS: The utilization of antiemetics in cancer outpatients and inpatients from 87 hospitals involved in “Hospital Prescription Analysis” project during 2012-2014 was analyzed statistically by time or by hospital category. RESULTS: 14 antiemetics were used in 87 hospitals during 2012-2014. The consumption sum and person number of antiemetics in cancer outpatients were 5 763 000 yuan and 34 000 persons [22 000 yuan/(year·hospital), 133.1 person/(year·hospital) in average]; those of cancer inpatients were 61 711 000 yuan and 515 000 persons [256 000 yuan/(year·hospital), 2 137.9 person/(year·hospital) in average]; those of outpatient were lower than those of inpatient. The ratio of consumption sum of antiemetics in cancer outpatients and inpatients were 5.2‰-34.0‰; the ratio of person number ranged 2.9%-10.9%. Those of inpatient were higher than those of outpatient; those of special hospital were higher than those of comprehensive hospital. Main drugs included ondansetron, tropisetron, metoclopramide and palonosetron. CONCLUSIONS: Antiemetics are frequently used in cancer patients, especially for 5-HT3 receptor antagonists and metoclopramide.
期刊: 2017年第28卷第11期
作者: 林平,张威,甄健存
AUTHORS: LIN Ping,ZHANG Wei,ZHEN Jiancun
关键字: 肿瘤;止吐药;用药分析;合理用药
KEYWORDS: Cancer; Antiemetics; Analysis of drug utilization; Rational use
阅读数: 129 次
本月下载数: 11 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!